Ionis Stock: An Innovating Biotech Angling For Leadership In RNA Therapy - Investor's Business Daily

Ionis Stock: An Innovating Biotech Angling For Leadership In RNA Therapy  Investor's Business Daily

Ionis stock has risen 34% this year as it takes on the RNA therapy space. Over the next two years, Ionis plans to send 10 drugs into Phase 3 testing.

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)